Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP
-
- Joanna Davis
- University of Miami Hemophilia Treatment Center, Miami, FL, USA;
-
- Songkai Yan
- CSL Behring, King of Prussia, PA, USA;
-
- Tadashi Matsushita
- Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan;
-
- Lorenzo Alberio
- Division of Hematology and Central Hematology Laboratory, Lausanne University Hospital (CHUV), Lausanne, Switzerland;
-
- Paul Bassett
- Meridian HealthComms, Cheshire, UK;
-
- Elena Santagostino
- Foundation IRCCS Ca’ Granda Maggiore Hospital Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy
収録刊行物
-
- Journal of Medical Economics
-
Journal of Medical Economics 22 (10), 1014-1021, 2019-06-05
Informa UK Limited
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1361131419071267712
-
- ISSN
- 1941837X
- 13696998
-
- データソース種別
-
- Crossref
- KAKEN